Geriatric wellness, healthy aging protocols, sarcopenia prevention, osteoporosis bone density, and memory care.
Senior Healthcare & LongevityAging does not necessarily lead to sarcopenia and osteopenia. We provide evidence-based clinical strategies to include progressive resistance exercise, a leucine rich protein diet, balance/vestibular exercises and fall prevention strategies at home.
Senior Healthcare & LongevityBackground: Benign prostatic hyperplasia refers to a benign adenomatous proliferation of the transition zone within the prostate. This affects >70% of men over the age of 60 years. Describe the presentation of obstructive / irritative lower urinary tract symptoms. Describe the scoring system (IPSS), assessment of PSA levels, management with alpha-1 blockers, 5-alpha reductase inhibitors and minimally invasive surgical interventions.
Senior Healthcare & LongevityChronic Kidney Disease describes progressive irreversible kidney damage over a period of more than 3 months. There are 5 stages of CKD according to the estimated Glomerular Filtration Rate (eGFR) and the levels of albuminuria. This section will cover KDIGO staging heatmaps, metabolic complications e.g. hyperkalemia, hyperphosphatemia & renal anaemia and renal specific medical nutrition therapy.
Senior Healthcare & LongevityDescribe osteoporosis. A skeletal system disease that leads to decreased bone mineral density. It also causes structural damage to the bones. This results into fragile bones, and increases the risk of fractures. Describe the cell biology of osteoclasts and osteoblasts. DEXA scans, T scores, FRAX, anti-resorptives and anabolic drugs used to treat bones, and progressive resistance exercises.
Senior Healthcare & LongevityOutline the neurological features of dementia (progressive decline in cognition that affects independent function). Describe the pathological features of Alzheimer's Disease including extra-cellular amyloid beta plaques and intra-cellular hyper-phosphorylated tau neurofibrillary tangles, describe the tools used to screen for cognition (MoCA, Mini-Cog). Identify reversible causes of pseudo-dementia and discuss Monoclonal antibody treatments that alter the course of disease.
